MedTech Dive April 25, 2024
Nick Paul Taylor

Exo sees the new capabilities as especially helpful for healthcare providers in rural and under-resourced settings.

Dive Brief:

  • Exo has made new artificial intelligence tools available on its Iris handheld ultrasound system, the company said Tuesday.
  • The Food and Drug Administration cleared Exo’s AI tools for analyzing ultrasound images of the heart and lung last year.
  • Exo sees the new capabilities as particularly beneficial for health systems and caregivers in rural and under-resourced settings because they simplify the collection and interpretation of images.

Dive Insight:

Exo received a 510(k) nod for its original Iris device in 2021 and added imaging modes and indications to the clearance the following year. The clearances cover handheld portable diagnostic ultrasound systems,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
Related Articles:
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

Share This Article